Association between Psychiatric Disorders and Amyotrophic Lateral Sclerosis: A Prospective Cohort Study from the UK Biobank

2.

Li

C

,

Liu

J

,

Lin

J

,

Shang

H

.

COVID-19 and risk of neurodegenerative disorders: a Mendelian randomization study

.

Transl Psychiatry

.

2022

;

12

(

1

):

283

.

3.

Phukan

J

,

Elamin

M

,

Bede

P

,

Jordan

N

,

Gallagher

L

,

Byrne

S

, et al.

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

.

J Neurol Neurosurg Psychiatry

.

2012

;

83

(

1

):

102

–

8

.

4.

Montuschi

A

,

Iazzolino

B

,

Calvo

A

,

Moglia

C

,

Lopiano

L

,

Restagno

G

, et al.

Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy

.

J Neurol Neurosurg Psychiatry

.

2015

;

86

(

2

):

168

–

73

.

5.

Masrori

P

,

Van Damme

P

.

Amyotrophic lateral sclerosis: a clinical review

.

Eur J Neurol

.

2020

;

27

(

10

):

1918

–

29

.

6.

Longinetti

E

,

Mariosa

D

,

Larsson

H

,

Ye

W

,

Ingre

C

,

Almqvist

C

, et al.

Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis

.

Neurology

.

2017

;

89

(

6

):

578

–

85

.

7.

Turner

MR

,

Goldacre

R

,

Talbot

K

,

Goldacre

MJ

.

Psychiatric disorders prior to amyotrophic lateral sclerosis

.

Ann Neurol

.

2016

;

80

(

6

):

935

–

8

.

8.

Körner

S

,

Kollewe

K

,

Ilsemann

J

,

Müller-Heine

A

,

Dengler

R

,

Krampfl

K

, et al.

Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis

.

Eur J Neurol

.

2013

;

20

(

4

):

647

–

54

.

9.

Roos

E

,

Mariosa

D

,

Ingre

C

,

Lundholm

C

,

Wirdefeldt

K

,

Roos

PM

, et al.

Depression in amyotrophic lateral sclerosis

.

Neurology

.

2016

;

86

(

24

):

2271

–

7

.

10.

Gustafsson

H

,

Nordström

A

,

Nordström

P

.

Depression and subsequent risk of Parkinson disease: a nationwide cohort study

.

Neurology

.

2015

;

84

(

24

):

2422

–

9

.

11.

Ismail

Z

,

Smith

EE

,

Geda

Y

,

Sultzer

D

,

Brodaty

H

,

Smith

G

, et al.

Neuropsychiatric symptoms as early manifestations of emergent dementia: provisional diagnostic criteria for mild behavioral impairment

.

Alzheimers Dement

.

2016

;

12

(

2

):

195

–

202

.

12.

Seelen

M

,

van Doormaal

PT

,

Visser

AE

,

Huisman

MH

,

Roozekrans

MH

,

de Jong

SW

, et al.

Prior medical conditions and the risk of amyotrophic lateral sclerosis

.

J Neurol

.

2014

;

261

(

10

):

1949

–

56

.

13.

Trabjerg

BB

,

Garton

FC

,

van Rheenen

W

,

Fang

F

,

Henderson

RD

,

Mortensen

PB

, et al.

ALS in Danish Registries: heritability and links to psychiatric and cardiovascular disorders

.

Neurol Genet

.

2020

;

6

(

2

):

e398

.

14.

Parkin Kullmann

JA

,

Hayes

S

,

Pamphlett

R

.

Is psychological stress a predisposing factor for Amyotrophic Lateral Sclerosis (ALS)? An online international case-control study of premorbid life events, occupational stress, resilience and anxiety

.

PLoS One

.

2018

;

13

(

9

):

e0204424

.

15.

Song

H

,

Sieurin

J

,

Wirdefeldt

K

,

Pedersen

NL

,

Almqvist

C

,

Larsson

H

, et al.

Association of stress-related disorders with subsequent neurodegenerative diseases

.

JAMA Neurol

.

2020

;

77

(

6

):

700

–

9

.

16.

Sudlow

C

,

Gallacher

J

,

Allen

N

,

Beral

V

,

Burton

P

,

Danesh

J

, et al.

UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age

.

PLoS Med

.

2015

;

12

(

3

):

e1001779

.

17.

O'Brien

M

,

Burke

T

,

Heverin

M

,

Vajda

A

,

McLaughlin

R

,

Gibbons

J

, et al.

Clustering of neuropsychiatric disease in first-degree and second-degree relatives of patients with amyotrophic lateral sclerosis

.

JAMA Neurol

.

2017

;

74

(

12

):

1425

–

30

.

18.

UK Biobank [Internet]

.

Algorithmically defined outcomes (ADOs)

. [cited 2024 Jul 26]. Available from: https://biobank.ndph.ox.ac.uk/showcase/refer.cgi?id=460

19.

Julian

TH

,

Glascow

N

,

Barry

ADF

,

Moll

T

,

Harvey

C

,

Klimentidis

YC

, et al.

Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes

.

EBioMedicine

.

2021

;

68

:

103397

.

20.

Ingre

C

,

Roos

PM

,

Piehl

F

,

Kamel

F

,

Fang

F

.

Risk factors for amyotrophic lateral sclerosis

.

Clin Epidemiol

.

2015

;

7

:

181

–

93

.

21.

Hendriks

S

,

Ranson

JM

,

Peetoom

K

,

Lourida

I

,

Tai

XY

,

de Vugt

M

, et al.

Risk factors for young-onset dementia in the UK biobank

.

JAMA Neurol

.

2024

;

81

(

2

):

134

–

42

.

22.

McHutchison

CA

,

Leighton

DJ

,

McIntosh

A

,

Cleary

E

,

Warner

J

,

Porteous

M

, et al.

Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND

.

J Neurol Neurosurg Psychiatry

.

2020

;

91

(

3

):

245

–

53

.

23.

Li

AWY

,

Hui

CLM

,

Lee

EHM

,

Chang

WC

,

Chan

SKW

,

Chen

EYH

.

Gender differences in correlates of cognition in first-episode psychosis

.

Psychiatry Res

.

2019

;

271

:

412

–

20

.

24.

Palmieri

A

,

Mento

G

,

Calvo

V

,

Querin

G

,

D’Ascenzo

C

,

Volpato

C

, et al.

Female gender doubles executive dysfunction risk in ALS: a case-control study in 165 patients

.

J Neurol Neurosurg Psychiatry

.

2015

;

86

(

5

):

574

–

9

.

25.

Tse

NY

,

Tu

S

,

Chen

Y

,

Caga

J

,

Dobson-Stone

C

,

Kwok

JB

, et al.

Schizotypal traits across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: pathomechanistic insights

.

J Neurol

.

2022

;

269

(

8

):

4241

–

52

.

26.

Birur

B

,

Kraguljac

NV

,

Shelton

RC

,

Lahti

AC

.

Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature

.

NPJ Schizophr

.

2017

;

3

:

15

.

27.

Lenzenweger

MF

.

Schizotypy, schizotypic psychopathology and schizophrenia

.

World Psychiatr

.

2018

;

17

(

1

):

25

–

6

.

28.

Wiesner

D

,

Feldengut

S

,

Woelfle

S

,

Boeckers

TM

,

Ludolph

AC

,

Roselli

F

, et al.

Neuropeptide FF (NPFF)-positive nerve cells of the human cerebral cortex and white matter in controls, selected neurodegenerative diseases, and schizophrenia

.

Acta Neuropathol Commun

.

2024

;

12

(

1

):

108

.

29.

Smeyers

J

,

Banchi

EG

,

Latouche

M

.

C9ORF72: what it is, what it does, and why it matters

.

Front Cell Neurosci

.

2021

;

15

:

661447

.

30.

Silverman

HE

,

Goldman

JS

,

Huey

ED

.

Links between the C9orf72 repeat expansion and psychiatric symptoms

.

Curr Neurol Neurosci Rep

.

2019

;

19

(

12

):

93

.

31.

Ducharme

S

,

Bajestan

S

,

Dickerson

BC

,

Voon

V

.

Psychiatric presentations of C9orf72 mutation: what are the diagnostic implications for clinicians

.

J Neuropsychiatry Clin Neurosci

.

2017

;

29

(

3

):

195

–

205

.

32.

Watson

A

,

Pribadi

M

,

Chowdari

K

,

Clifton

S

,

Joel

W

,

Miller

BL

, et al.

C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis

.

Psychiatry Res

.

2016

;

235

:

200

–

2

.

33.

Devenney

EM

,

Tu

S

,

Caga

J

,

Ahmed

RM

,

Ramsey

E

,

Zoing

M

, et al.

Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS-FTD spectrum

.

Ann Clin Transl Neurol

.

2021

;

8

(

8

):

1576

–

91

.

34.

McLaughlin

RL

,

Schijven

D

,

van Rheenen

W

,

van Eijk

KR

,

O'Brien

M

,

Kahn

RS

, et al.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

.

Nat Commun

.

2017

;

8

:

14774

.

35.

Restuadi

R

,

Garton

FC

,

Benyamin

B

,

Lin

T

,

Williams

KL

,

Vinkhuyzen

A

, et al.

Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia

.

Eur J Hum Genet

.

2022

;

30

(

5

):

532

–

9

.

36.

Li

C

,

Yang

T

,

Ou

R

,

Shang

H

.

Overlapping genetic architecture between schizophrenia and neurodegenerative disorders

.

Front Cell Dev Biol

.

2021

;

9

:

797072

.

37.

Choi

SJ

,

Park

CHK

,

Hong

YH

,

Sung

JJ

.

Previous psychiatric disorders in the multistep hypothesis of amyotrophic lateral sclerosis: a South Korean population study

.

Amyotroph Lateral Scler Frontotemporal Degener

.

2022

;

23

(

7–8

):

601

–

7

.

38.

DuMont

M

,

Agostinis

A

,

Singh

K

,

Swan

E

,

Buttle

Y

,

Tropea

D

.

Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies

.

Neurobiol Dis

.

2023

;

184

:

106214

.

39.

Grassano

M

,

Moglia

C

,

Palumbo

F

,

Koumantakis

E

,

Cugnasco

P

,

Callegaro

S

, et al.

Sex differences in amyotrophic lateral sclerosis survival and progression: a multidimensional analysis

.

Ann Neurol

.

2024

;

96

(

1

):

159

–

69

.

40.

Moglia

C

,

Calvo

A

,

Grassano

M

,

Canosa

A

,

Manera

U

,

D'Ovidio

F

, et al.

Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort

.

J Neurol Neurosurg Psychiatry

.

2019

;

90

(

6

):

666

–

73

.

41.

Karageorgiou

V

,

Casanova

F

,

O'Loughlin

J

,

Green

H

,

McKinley

TJ

,

Bowden

J

, et al.

Body mass index and inflammation in depression and treatment-resistant depression: a Mendelian randomisation study

.

BMC Med

.

2023

;

21

(

1

):

355

.

42.

Tyrrell

J

,

Mulugeta

A

,

Wood

AR

,

Zhou

A

,

Beaumont

RN

,

Tuke

MA

, et al.

Using genetics to understand the causal influence of higher BMI on depression

.

Int J Epidemiol

.

2019

;

48

(

3

):

834

–

48

.

43.

Westeneng

HJ

,

van Veenhuijzen

K

,

van der Spek

RA

,

Peters

S

,

Visser

AE

,

van Rheenen

W

, et al.

Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study

.

Lancet Neurol

.

2021

;

20

(

5

):

373

–

84

.

44.

Zhang

L

,

Tang

L

,

Huang

T

,

Fan

D

.

Life course adiposity and amyotrophic lateral sclerosis: a mendelian randomization study

.

Ann Neurol

.

2020

;

87

(

3

):

434

–

41

.

45.

Zeng

P

,

Yu

X

,

Xu

H

.

Association between premorbid body mass index and amyotrophic lateral sclerosis: causal inference through genetic approaches

.

Front Neurol

.

2019

;

10

:

543

.

46.

Abdelhak

A

,

Foschi

M

,

Abu-Rumeileh

S

,

Yue

JK

,

D’Anna

L

,

Huss

A

, et al.

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

.

Nat Rev Neurol

.

2022

;

18

(

3

):

158

–

72

.

47.

Verkhratsky

A

,

Parpura

V

.

Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders

.

Neurobiol Dis

.

2016

;

85

:

254

–

61

.

48.

Steinacker

P

,

Al Shweiki

MR

,

Oeckl

P

,

Graf

H

,

Ludolph

AC

,

Schönfeldt-Lecuona

C

, et al.

Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder

.

J Psychiatr Res

.

2021

;

144

:

54

–

8

.

49.

Benninger

F

,

Glat

MJ

,

Offen

D

,

Steiner

I

.

Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis

.

J Clin Neurosci

.

2016

;

26

:

75

–

8

.

50.

Verde

F

,

Milone

I

,

Maranzano

A

,

Colombo

E

,

Torre

S

,

Solca

F

, et al.

Serum levels of glial fibrillary acidic protein in patients with amyotrophic lateral sclerosis

.

Ann Clin Transl Neurol

.

2023

;

10

(

1

):

118

–

29

.

51.

Falzone

YM

,

Domi

T

,

Mandelli

A

,

Pozzi

L

,

Schito

P

,

Russo

T

, et al.

Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis

.

Eur J Neurol

.

2022

;

29

(

7

):

1930

–

9

.

52.

Mastrangelo

A

,

Vacchiano

V

,

Zenesini

C

,

Ruggeri

E

,

Baiardi

S

,

Cherici

A

, et al.

Amyloid-beta Co-pathology is a major determinant of the elevated plasma GFAP values in amyotrophic lateral sclerosis

.

Int J Mol Sci

.

2023

;

24

(

18

):

13976

.

53.

Michel

M

,

Fiebich

BL

,

Kuzior

H

,

Meixensberger

S

,

Berger

B

,

Maier

S

, et al.

Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression

.

Transl Psychiatry

.

2021

;

11

(

1

):

308

.

54.

Garton

FC

,

Trabjerg

BB

,

Wray

NR

,

Agerbo

E

.

Cardiovascular disease, psychiatric diagnosis and sex differences in the multistep hypothesis of amyotrophic lateral sclerosis

.

Eur J Neurol

.

2021

;

28

(

2

):

421

–

9

.

55.

Horrocks

S

,

Wilkinson

T

,

Schnier

C

,

Ly

A

,

Woodfield

R

,

Rannikmäe

K

, et al.

Accuracy of routinely-collected healthcare data for identifying motor neurone disease cases: a systematic review

.

PLoS One

.

2017

;

12

(

2

):

e0172639

.

56.

Fry

A

,

Littlejohns

TJ

,

Sudlow

C

,

Doherty

N

,

Adamska

L

,

Sprosen

T

, et al.

Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population

.

Am J Epidemiol

.

2017

;

186

(

9

):

1026

–

34

.